Pilot Cardiac Evaluation For Fitness for Duty

Issues of Concern

Common Cardiac Arrhythmias

Aeromedical concerns regarding cardiac arrhythmias in aviators include the risk of sudden incapacitation, hemodynamic symptoms, recurrences, and treatment modality.

Bradycardia 

FAA certification requires documentation of history and findings, cardiovascular events, and any test deemed appropriate for all medical classes, including bradycardia (<50 beats per minute). If no evidence of coronary artery disease is documented, the aeromedical examiner may issue a medical certificate.

Wolff-Parkinson-White Syndrome and ECG Pattern

The Wolff-Parkinson-White syndrome (WPW) pattern is an ECG finding without supraventricular tachycardia, whereas WPW is an ECG finding with supraventricular tachycardia. The aeromedical concern with WPW is sudden cardiac death (SCD). SCD is due to the occurrence of malignant arrhythmias from rapid anterograde action potential conduction in the setting of atrial fibrillation. Pappone et al report that sudden cardiac death occurs in 0.0% to 0.8% per year or 1.4% over 5 years in patients with WPW and report that sudden cardiac death cannot be predicted. Other studies determined predictors of SCD as young age, male gender, inducible antidromic atrioventricular reentry tachycardia (AVRT), multiple accessory pathways, and short refractory period of the pathway.

According to the United States Air Force waiver guide, the WPW pattern disqualifies all classes. A waiver is possible after noninvasive testing shows low risk with annual follow-up. These guidelines continue to change, so referring to the waiver guide for current aeromedical disposition is imperative. Catheter ablation for WPW in an aviator requires a 3-month grounding period and further evaluation by a cardiologist to stratify risk.[7][8]

Left and Right Bundle Block for all Classes of Medical Certification

Left and right bundle block (LBBB) will not occur in aircrew younger than 25. It is rare in aircrew 25 to 35 years old, and most occur in aircrew older than 35. Right Bundle block is a normal variant in young aircrew, and further investigation is not required.

The FAA requires a cardiovascular evaluation and a graded exercise test (GXT). A medical certificate can be issued if there is no evidence of coronary artery disease. Otherwise, deferral to the FAA is required.

Atrial Fibrillation

Paroxysmal atrial fibrillation is of greater concern aeromedically than chronic atrial fibrillation. In military aviation, rate control medications for atrial fibrillation are not compatible with the +Gz environment. Chronic and paroxysmal atrial fibrillation requires an FAA decision.

Valvular Heart Disease

In a study by Strader JR and Kruyer WB et al, regarding the efficacy of echocardiographic screening of Pilot Applicants, 20,208 screening ECGs were analyzed, and 294 or 1.45% were initially read as disqualifying for flight duties. The most common diagnosis was bicuspid aortic valve with mild or less aortic insufficiency 154 (0.76%), mitral valve prolapse with mild mitral regurgitation 51 (0.25%), and tri leaflet aortic valve with mild aortic insufficiency 58 (0.29%).

About 70% of patients with bicuspid aortic valve develop aortic valve insufficiency and or aortic stenosis in their lifetime. Pilots with healthy functioning bicuspid aortic valves are fit for unrestricted flying, but periodic echocardiography to monitor complications is required. Aircrews with mitral valve prolapse and mild mitral regurgitation may continue flying duties with regular surveillance for complications.

Coronary Heart Disease and Interventions

It is usually disqualifying and requires an FAA decision. The United Kingdom Civil Aviation Authority (CAA) requires a 6-month grounding before a cardiologist assessment. In the United States Air Force (USAF) guidelines, a pilot with a history of previous myocardial infarction or revascularization has the potential to return to flying with a waiver on a case-by-case basis if he or she has no residual ischemia with normal cardiac function. The return to fly status depends on how much coronary artery disease is appreciated, and the pilot is likely restricted to multiple-pilot aircraft. Coronary artery calcium (CAC) scoring is a useful screening criterion in asymptomatic patients. It is a much more effective tool than a treadmill stress test or functional cardiac imaging, as these have poor positive predictive value. It even mirrors the results seen in invasive angiography. A CAC score of 10 to 99 was associated with a cardiac event of roughly 1%, so the current criteria for not needing a waiver for flying in USAF standards is a CAC of less than 10.[9][10]

Hypertension

The FAA’s acceptable blood pressure limit is a systolic blood pressure of less than or equal to 155 mmHg and diastolic blood pressure of less than or equal to 95 mmHg. The United States Aeromedical Consultation Service defines hypertension for aeromedical purposes as a three-day average systolic blood pressure greater than 140 mmHg or diastolic blood pressure greater than 90 mmHg.

Treatment of hypertension reduces the risk of stroke by 35 to 40%, myocardial infarction by 20 to 25%, and heart failure by 50%. In aviators younger than 35 years old, causes of secondary hypertension like alcohol, drugs, obesity, and renal problems should be considered. Modifiable risk factors should be considered as first-line treatment in aviators.

The FAA-acceptable medications are alpha-adrenergic blockers, angiotensin-converting enzyme (ACE) inhibitors, beta-blockers, calcium channel blockers, angiotensin II receptor antagonists, direct renin inhibitors, and diuretics. Unacceptable medications are centrally acting, including clonidine, guanabenz, guanfacine, methyldopa, nitrates, and reserpine.

The USAF acceptable medications are hydrochlorothiazide (thiazide diuretic), chlorothiazide (thiazide diuretic), triamterene (potassium sparing diuretic), lisinopril, ramipril, losartan, and telmisartan (ARA). Beta-blockers, calcium channel blockers, and alpha-blockers are unacceptable medications in military aviation. Atenolol, nifedipine, and amlodipine may be restricted for a flight crew that does not operate in high +Gz environments.

Clinical Significance

Cardiovascular disease is the leading cause of morbidity and mortality in the United States and, hence, a major area of concern for aeromedical decision-making and aircrew medical standards. It is also a leading cause of loss of medical license or issuance of a waiver in the aircrew population in both civilian and military aviation. Healthcare workers, including the nurse practitioner, should ensure a thorough preoperative cardiac workup in this population because work is often required.